Hepatic veno-occlusive disease after hematopoietic stem cell transplantation: update on defibrotide and other current investigational therapies (Q36997723)

From Wikidata

Jump to navigation Jump to search

scientific article published on 12 November 2007

Language	Label	Description	Also known as
English	Hepatic veno-occlusive disease after hematopoietic stem cell transplantation: update on defibrotide and other current investigational therapies	scientific article published on 12 November 2007

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

17 August 2017

1 reference

Europe PubMed Central

Hepatic veno-occlusive disease after hematopoietic stem cell transplantation: update on defibrotide and other current investigational therapies (English)

1 reference

Europe PubMed Central

PubMed publication ID

17 August 2017

hepatic veno-occlusive disease

1 reference

based on heuristic

inferred from title

author name string

V T Ho

1

1 reference

Europe PubMed Central

PubMed publication ID

17 August 2017

C Revta

2

1 reference

Europe PubMed Central

PubMed publication ID

17 August 2017

P G Richardson

3

1 reference

Europe PubMed Central

PubMed publication ID

17 August 2017

language of work or name

0 references

publication date

12 November 2007

1 reference

Europe PubMed Central

PubMed publication ID

17 August 2017

Bone Marrow Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

17 August 2017

41

1 reference

Europe PubMed Central

PubMed publication ID

17 August 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

17 August 2017

229-237

1 reference

Europe PubMed Central

PubMed publication ID

17 August 2017

Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705899

21 January 2018

Prophylactic reinfusion of T cells for T cell-depleted allogeneic bone marrow transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705899

21 January 2018

Hepatic injury after nonmyeloablative conditioning followed by allogeneic hematopoietic cell transplantation: a study of 193 patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705899

21 January 2018

Hemostatic complications in bone marrow transplantation: a retrospective analysis of 447 patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705899

21 January 2018

Multi-institutional use of defibrotide in 88 patients after stem cell transplantation with severe veno-occlusive disease and multisystem organ failure: response without significant toxicity in a high-risk population and factors predictive of outcome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705899

21 January 2018

Cellular target of cyclophosphamide toxicity in the murine liver: role of glutathione and site of metabolic activation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705899

21 January 2018

High exposures to bioactivated cyclophosphamide are related to the occurrence of veno-occlusive disease of the liver following high-dose chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705899

21 January 2018

Plasminogen activator inhibitor-1 is an independent diagnostic marker as well as severity predictor of hepatic veno-occlusive disease after allogeneic bone marrow transplantation in adults conditioned with busulphan and cyclophosphamide

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705899

21 January 2018

Transforming growth factor beta-1 released from platelets contributes to hypercoagulability in veno-occlusive disease following hematopoetic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705899

21 January 2018

Pivotal role of PAI-1 in a murine model of hepatic vein thrombosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705899

21 January 2018

Toxic injury to hepatic sinusoids: sinusoidal obstruction syndrome (veno-occlusive disease).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705899

21 January 2018

Positive selection for CD34+ reduces the incidence and severity of veno-occlusive disease of the liver after HLA-identical sibling allogeneic peripheral blood stem cell transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705899

21 January 2018

Busulfan levels are influenced by prior treatment and are associated with hepatic veno-occlusive disease and early mortality but not with delayed complications following marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705899

21 January 2018

Cyclophosphamide metabolism, liver toxicity, and mortality following hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705899

21 January 2018

Decreased incidence of hepatic veno-occlusive disease and fewer hemostatic derangements associated with intravenous busulfan vs oral busulfan in adults conditioned with busulfan + cyclophosphamide for allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705899

21 January 2018

Prior gemtuzumab ozogamicin exposure significantly increases the risk of veno-occlusive disease in patients who undergo myeloablative allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705899

21 January 2018

Safety and efficacy of gemtuzumab ozogamicin in pediatric patients with advanced CD33+ acute myeloid leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705899

21 January 2018

Marked reduction in the incidence of hepatic veno-occlusive disease after allogeneic hematopoietic stem cell transplantation with CD34(+) positive selection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705899

21 January 2018

Sirolimus, tacrolimus, and low-dose methotrexate for graft-versus-host disease prophylaxis in mismatched related donor or unrelated donor transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705899

21 January 2018

Sirolimus and thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705899

21 January 2018

Fludarabine induces apoptosis, activation, and allogenicity in human endothelial and epithelial cells: protective effect of defibrotide

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705899

21 January 2018

Defibrotide, a single-stranded polydeoxyribonucleotide acting as an adenosine receptor agonist

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705899

21 January 2018

Prophylaxis with defibrotide prevents veno-occlusive disease in stem cell transplantation after gemtuzumab ozogamicin exposure.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705899

21 January 2018

Alteplase for hepatic veno-occlusive disease complicating bone-marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705899

21 January 2018

Successful treatment of an infant with veno-occlusive disease developed after allogeneic bone marrow transplantation by tissue plasminogen activator, heparin and prostaglandin E1

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705899

21 January 2018

Veno-occlusive disease (VOD) of the liver in Korean patients following allogeneic bone marrow transplantation (BMT): efficacy of recombinant human tissue plasminogen activator (rt-PA) treatment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705899

21 January 2018

Antithrombin treatment of severe hepatic veno-occlusive disease in children with cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705899

21 January 2018

Anti-thrombin III in the management of hematopoietic stem-cell transplantation-associated toxicity.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705899

21 January 2018

Low molecular weight heparin for the prevention of veno-occlusive disease of the liver in bone marrow transplantation patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705899

21 January 2018

Retrospective multivariate analysis of hepatic veno-occlusive disease after blood or marrow transplantation: possible beneficial use of low molecular weight heparin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705899

21 January 2018

A randomized trial of heparin plus ursodiol vs. heparin alone to prevent hepatic veno-occlusive disease after hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705899

21 January 2018

Low molecular weight heparin for the prevention of hepatic veno-occlusive disease (VOD) after hematopoietic stem cell transplantation: a prospective phase II study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705899

21 January 2018

Ursodeoxycholic acid for the prevention of hepatic complications in allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705899

21 January 2018

Hepatic dysfunction following T-cell-depleted allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705899

21 January 2018

The effect of busulphan on the pharmacokinetics of cyclophosphamide and its 4-hydroxy metabolite: time interval influence on therapeutic efficacy and therapy-related toxicity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705899

21 January 2018

Regimen-related toxicity in patients undergoing bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705899

7 January 2021

based on heuristic

inferred from DOI database lookup

Veno-occlusive disease of the liver after busulfan, melphalan, and thiotepa conditioning therapy: incidence, risk factors, and outcome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705899

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevention and treatment of hepatic venocclusive disease after high-dose cytoreductive therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705899

7 January 2021

based on heuristic

inferred from DOI database lookup

Defibrotide for the treatment of hepatic veno-occlusive disease: results of the European compassionate-use study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705899

7 January 2021

based on heuristic

inferred from DOI database lookup

Defibrotide in the treatment of children with veno-occlusive disease (VOD): a retrospective multicentre study demonstrates therapeutic efficacy upon early intervention

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705899

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevention of veno-occlusive disease with defibrotide after allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705899

7 January 2021

based on heuristic

inferred from DOI database lookup

Stem cell transplantation in children with infantile osteopetrosis is associated with a high incidence of VOD, which could be prevented with defibrotide

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705899

7 January 2021

based on heuristic

inferred from DOI database lookup

Prophylactic defibrotide in allogeneic stem cell transplantation: minimal morbidity and zero mortality from veno-occlusive disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705899

7 January 2021

based on heuristic

inferred from DOI database lookup

Endothelial dysfunction after bone marrow transplantation: increase of soluble thrombomodulin and PAI-1 in patients with multiple transplant-related complications

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705899

7 January 2021

based on heuristic

inferred from DOI database lookup

Transforming growth factor beta as a predictor of liver and lung fibrosis after autologous bone marrow transplantation for advanced breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705899

7 January 2021

based on heuristic

inferred from DOI database lookup

Decreased hepatic nitric oxide production contributes to the development of rat sinusoidal obstruction syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705899

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatic Veno-occlusive Disease (Sinusoidal Obstruction Syndrome) After Hematopoietic Stem Cell Transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705899

7 January 2021

based on heuristic

inferred from DOI database lookup

Regimen-related toxicity of a busulfan-cyclophosphamide conditioning regimen in 70 patients undergoing allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705899

7 January 2021

based on heuristic

inferred from DOI database lookup

Association of pulmonary function testing abnormalities and severe veno-occlusive disease of the liver after marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705899

7 January 2021

based on heuristic

inferred from DOI database lookup

Absence of veno-occlussive disease in a cohort of multiple myeloma patients undergoing autologous stem cell transplantation with targeted busulfan dosage

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705899

7 January 2021

based on heuristic

inferred from DOI database lookup

Cyclophosphamide following Targeted Oral Busulfan as Conditioning for Hematopoietic Cell Transplantation: Pharmacokinetics, Liver Toxicity, and Mortality

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705899

7 January 2021

based on heuristic

inferred from DOI database lookup

Gemtuzumab ozogamicin-associated sinusoidal obstructive syndrome (SOS): an overview from the research on adverse drug events and reports (RADAR) project

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705899

7 January 2021

based on heuristic

inferred from DOI database lookup

Isolation and identification of aptamers from defibrotide that act as thrombin antagonists in vitro

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705899

7 January 2021

based on heuristic

inferred from DOI database lookup

Acute effects of defibrotide, an experimental antithrombotic agent, on fibrinolysis and blood prostanoids in man

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705899

7 January 2021

based on heuristic

inferred from DOI database lookup

Defibrotide, by enhancing prostacyclin generation, prevents endothelin-1 induced contraction in human saphenous veins

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705899

7 January 2021

based on heuristic

inferred from DOI database lookup

Defibrotide for the treatment of hepatic veno-occlusive disease in children

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705899

7 January 2021

based on heuristic

inferred from DOI database lookup

Venoocclusive disease of the liver: development of a model for predicting fatal outcome after marrow transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705899

7 January 2021

based on heuristic

inferred from DOI database lookup

Alteplase for hepatic veno-occlusive disease after bone-marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705899

7 January 2021

based on heuristic

inferred from DOI database lookup

Alteplase for hepatic veno-occlusive disease after bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705899

7 January 2021

based on heuristic

inferred from DOI database lookup

Recombinant tissue plasminogen activator (rt-PA) for veno-occlusive liver disease in pediatric autologous bone marrow transplant patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705899

7 January 2021

based on heuristic

inferred from DOI database lookup

Tissue plasminogen activator (tPA) as therapy for hepatotoxicity following bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705899

7 January 2021

based on heuristic

inferred from DOI database lookup

Recombinant tissue plasminogen activator (rtPA) for the treatment of hepatic veno-occlusive disease (VOD)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705899

7 January 2021

based on heuristic

inferred from DOI database lookup

Antithrombin-III for the treatment of chemotherapy-induced organ dysfunction following bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705899

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatic veno-occlusive disease in pediatric stem cell recipients: successful treatment with continuous infusion of prostaglandin E1 and low-dose heparin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705899

7 January 2021

based on heuristic

inferred from DOI database lookup

A phase I/II study of prostaglandin E1 for the prevention of hepatic venocclusive disease after bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705899

7 January 2021

based on heuristic

inferred from DOI database lookup

Prophylactic heparin does not prevent liver veno-occlusive disease following autologous bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705899

7 January 2021

based on heuristic

inferred from DOI database lookup

The Japanese multicenter open randomized trial of ursodeoxycholic acid prophylaxis for hepatic veno-occlusive disease after stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705899

7 January 2021

based on heuristic

inferred from DOI database lookup

Ursodiol prophylaxis against hepatic complications of allogeneic bone marrow transplantation. A randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705899

7 January 2021

based on heuristic

inferred from DOI database lookup

Charcoal hemofiltration for hepatic veno-occlusive disease after hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705899

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.BMT.1705899

1 reference

Europe PubMed Central

PubMed publication ID

17 August 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

17 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36997723&oldid=2199711635"